Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review
Amsterdam UMC, Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Amsterdam Public Health Research Institute, Methodology, Amsterdam, Netherlands.
Amsterdam Public Health Research Institute, Methodology, Amsterdam, Netherlands; Amsterdam UMC, Department of General Practice, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Amsterdam Public Health Research Institute, Methodology, Amsterdam, Netherlands.
Amsterdam UMC, Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Show others and affiliations
2023 (English)In: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 66, no 8, p. 1357-1377Article, review/survey (Refereed) Published
Abstract [en]

Patient-reported outcomes (PROs) are valuable for shared decision making and research. Patient-reported outcome measures (PROMs) are questionnaires used to measure PROs, such as health-related quality of life (HRQL). Although core outcome sets for trials and clinical practice have been developed separately, they, as well as other initiatives, recommend different PROs and PROMs. In research and clinical practice, different PROMs are used (some generic, some disease-specific), which measure many different things. This is a threat to the validity of research and clinical findings in the field of diabetes. In this narrative review, we aim to provide recommendations for the selection of relevant PROs and psychometrically sound PROMs for people with diabetes for use in clinical practice and research. Based on a general conceptual framework of PROs, we suggest that relevant PROs to measure in people with diabetes are: disease-specific symptoms (e.g. worries about hypoglycaemia and diabetes distress), general symptoms (e.g. fatigue and depression), functional status, general health perceptions and overall quality of life. Generic PROMs such as the 36-Item Short Form Health Survey (SF-36), WHO Disability Assessment Schedule (WHODAS 2.0), or Patient-Reported Outcomes Measurement Information System (PROMIS) measures could be considered to measure commonly relevant PROs, supplemented with disease-specific PROMs where needed. However, none of the existing diabetes-specific PROM scales has been sufficiently validated, although the Diabetes Symptom Self-Care Inventory (DSSCI) for measuring diabetes-specific symptoms and the Diabetes Distress Scale (DDS) and Problem Areas in Diabetes (PAID) for measuring distress showed sufficient content validity. Standardisation and use of relevant PROs and psychometrically sound PROMs can help inform people with diabetes about the expected course of disease and treatment, for shared decision making, to monitor outcomes and to improve healthcare. We recommend further validation studies of diabetes-specific PROMs that have sufficient content validity for measuring disease-specific symptoms and consider generic item banks developed based on item response theory for measuring commonly relevant PROs.

Place, publisher, year, edition, pages
Springer, 2023. Vol. 66, no 8, p. 1357-1377
Keywords [en]
Diabetes, Patient-reported outcome, Patient-reported outcome measure, Review, Standardisation
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:umu:diva-209163DOI: 10.1007/s00125-023-05926-3ISI: 000994500100001PubMedID: 37222772Scopus ID: 2-s2.0-85160270888OAI: oai:DiVA.org:umu-209163DiVA, id: diva2:1765686
Available from: 2023-06-12 Created: 2023-06-12 Last updated: 2023-12-05Bibliographically approved

Open Access in DiVA

fulltext(828 kB)143 downloads
File information
File name FULLTEXT02.pdfFile size 828 kBChecksum SHA-512
90242b226f4e122401d854d2c47fe27b590a9a51f802ca128774798e46301a12c53b784bcdd8223847f77d966880d72f9d2e6e95a4c1ea54c30b14e3b83a372e
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Rolandsson, Olaf

Search in DiVA

By author/editor
Rolandsson, Olaf
By organisation
Family Medicine
In the same journal
Diabetologia
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 248 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 341 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf